Loading...
SUN PHARMACEUTICAL INDUSTRIES,INC. — Budesonide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #6 buyer for Budesonide · $2.0M import value · 67 shipments · UNITED STATES · DGFT Verified
SUN PHARMACEUTICAL INDUSTRIES,INC. is the #6 importer of Budesonide from India with $2.0M in import value and 67 verified shipments. SUN PHARMACEUTICAL INDUSTRIES,INC. holds a 1.1% market share in Budesonide imports based in UNITED STATES. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, SUN PHARMACEUTICAL INDUSTRIES,INC. imports 19 pharmaceutical products worth $33.2M across 10 therapeutic categories.
Verified from 67 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.0M | 67 | 100.0% |
SUN PHARMACEUTICAL INDUSTRIES,INC. sources Budesonide from 1 verified Indian supplier based on 67 customs records. The primary supplier is SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ACINO PHARMACEUTICALS FZ LLC | UNITED ARAB EMIRATES | $2.4M | 47 | $50.0K |
| 8 | BREATHEFREE LANKA PVT LTD | SRI LANKA | $2.2M | 44 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES,INC. ★ | UNITED STATES | $2.1M | 43 | $50.0K |
| 7 | BIOPHARM DISTRIBUTION SPA, | ALGERIA | $1.9M | 38 | $50.0K |
| 10 | SUN PHARMACEUTICAL INDUSTRIES INC ★ | UNITED STATES | $1.5M | 42 | $35.3K |
SUN PHARMACEUTICAL INDUSTRIES,INC. ranks #6 among 609 Budesonide importers from India. Average shipment value of $50.0K compared to the market average of $60.8K. The closest competitors by value are ACINO PHARMACEUTICALS FZ LLC and BREATHEFREE LANKA PVT LTD.
Destination countries from 67 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.0M | 67 | 100.0% |
SUN PHARMACEUTICAL INDUSTRIES,INC. imports Budesonide to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.0M.
| Formulation | Value | Shipments |
|---|---|---|
| BUDESONIDE INHALATION SUSPENSION, 0.5 MG/2ML PACK : 05*06 (BATCH NO AS PER INVOICE) | $435.6K | 13 |
| BUDESONIDE INHALATION SUSPENSION, 0.25 M | $300.0K | 6 |
| BUDESONIDE INHALATION SUSPENSION, 0.5 MG | $232.0K | 12 |
| BUDESONIDE INHALATION SUSPENSION, 0.5 MG/2ML PACK : 05*06 | $215.8K | 5 |
| BUDESONIDE INHALATION SUSPENSION, 1 MG/2 | $150.0K | 3 |
| BUDESONIDE INHALATION SUSPENSION, 0.25 MG/2ML PACK : 05*06 (BATCH NO AS PER INVOICE) | $150.0K | 3 |
| BUDESONIDE INHALATION SUSPENSION, 1 MG/2ML PACK : 05*06 (BATCH NO AS PER INVOICE) | $150.0K | 3 |
| Budesonide Suspension For Inhalation ,0 | $64.9K | 2 |
What SUN PHARMACEUTICAL INDUSTRIES,INC. and other importers must comply with to import Budesonide from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $37.0M worth of Budesonide through 9,145 shipments from 275 suppliers to 115 countries, serving 609 buyers globally. SUN PHARMACEUTICAL INDUSTRIES,INC. imports $2.0M of this total, accounting for 1.1% of India's Budesonide exports with 67 shipments from UNITED STATES. This is verified from 67 customs shipment records covering 17 distinct formulations.
SUN PHARMACEUTICAL INDUSTRIES,INC.'s average Budesonide order value is $30.0K per consignment, based on 67 shipments totaling $2.0M. SUN PHARMACEUTICAL INDUSTRIES,INC. is based in UNITED STATES and ranks #6 among all Budesonide importers from India by value. The company sources from 1 verified supplier in India.
SUN PHARMACEUTICAL INDUSTRIES,INC. sources Budesonide from 1 verified Indian supplier: SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.0M, 100.0%). This is based on 67 customs records.
SUN PHARMACEUTICAL INDUSTRIES,INC. ranks #6 among 609 Budesonide importers from India with a 1.1% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($16.6M), BIOPHARM DISTRIBUTION SPA ($3.0M), ACINO PHARMACEUTICALS FZ LLC ($2.4M). SUN PHARMACEUTICAL INDUSTRIES,INC. processed 67 shipments from UNITED STATES.
SUN PHARMACEUTICAL INDUSTRIES,INC. also imports these respiratory products. Each links to the detailed product page.
SUN PHARMACEUTICAL INDUSTRIES,INC. imports 19 products worth $33.2M. Beyond Budesonide, top products include Mesalamine, Doxorubicin, Ipratropium, Amphotericin, Ciprofloxacin. View the complete SUN PHARMACEUTICAL INDUSTRIES,INC. profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Budesonide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for SUN PHARMACEUTICAL INDUSTRIES,INC.'s Budesonide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN PHARMACEUTICAL INDUSTRIES,INC.
Full Company Profile →
19 products · $33.2M total trade · 10 categories
| BUDESONIDE INHALATION SUSPENSION, 1MG/2ML (BUDESONIDE SUSPENSION FOR INHALATION,1MG/ML (2ML AMPOULE) [6840 PACK X5X6]NOS | $62.2K | 3 |
| BUDESONIDE INHALATION SUSPENSION, 0.25 MG/2ML PACK : 05*06 | $61.8K | 2 |
SUN PHARMACEUTICAL INDUSTRIES,INC. imports 17 distinct Budesonide formulations from India. The top formulation is BUDESONIDE INHALATION SUSPENSION, 0.5 MG/2ML PACK : 05*06 (B with 13 shipments worth $435.6K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 609+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for SUN PHARMACEUTICAL INDUSTRIES,INC..
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Budesonide. For current order-level data, contact TransData Nexus.